Follow us
Source - FICCI FLO Pune
Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out
Adar Poonawalla Receives 'Udyog Mitra' Award From Government Of Maharashtra
Adar Poonawalla awarded 'Business Leader of the Year' 2023 by the International Advertising Association (IAA) India Chapter
Cyrus Poonawalla Group appoints Keki Mistry as Strategic Advisor to all the Financial Services Ventures led by Adar Poonawalla
UK Minister visits Serum Institute Of India
Adar Poonawalla featured on the ET Grandmasters Series
International Society for Pharmaceutical Engineering (ISPE) Awards for Serum Institute Of India
R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana
Forbes India Pathbreakers: Adar Poonawalla on vaccines, strategy, and legacy
Seth Berkley CEO of Gavi visits Serum Institute Of India
Serum Institute Of India launches the first made-in-India qHPV vaccine 'CERVAVAC'
Davos 2023: Chief executive of Serum Institute of India (SII) on achieving vaccine equity
Serum Institute of India CEO Adar Poonawalla receives Dr. Patangrao Kadam Memorial Award
Department of Biotechnology announces the scientific completion of India's first qHPV vaccine ‘CERVAVAC’
Serum Institute CEO calls on Hon'ble Prime Minister Shri. Narendra Modi
U.S. Delegation visits Serum Institute of India
Johns Hopkins Bloomberg School Of Public Health Awards Highest Honour To Dr. Cyrus S Poonawalla
Adar Poonawalla receives the Business Leader of The Year award at the Economic Times Awards
Covovax now available for children in India', says Adar Poonawalla
Business Leader of the Year - All India Management Association
Adar Poonawalla, CEO, Serum Institute of India, receives the award for the Outstanding Business Leader of the Year
Dr. Cyrus Poonawalla conferred with the Padma Bhushan Award
Covid-19: Covovax gets DCGI’s EUA nod for 12-17-year-olds
SII makes available vaccines at price of 'cup of tea' to poor nations, says Cyrus Poonawalla
CEO of Serum Institute of India is finding newer frontiers to invest - Forbes India
Will continue to work towards making health equitable for all: Dr Cyrus Poonawalla
Dr. Cyrus Poonawalla to be conferred with Padma Bhushan
Adar Poonawalla - India Today Newsmakers of the Year 2021
World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine 'COVOVAX™'
£50m funding for Poonawalla Vaccines Research Building at Oxford University
Serum Institute of India (SII) re-starts COVAX exports; passes 1 billion COVISHIELD dose milestone
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Serum Life Sciences Ltd announces Strategic Partnership with Oxford Biomedica
Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance
Adar Poonawalla - TIME 100 Most Influential People of 2021
SCHOTT and Serum Institute of India Announce Joint Venture for Pharmaceutical Packaging
Dr. Cyrus S. Poonawalla receives Lokmanya Tilak National Award 2021
Welcome Key Note speaker Mrs. Natasha Poonawalla at the SAYFTY Self-Care Summit
UK Secretary of State for International Trade, Liz Truss visits Serum Institute of India
Success Story of Cyrus Poonawalla: The man behind India's prestigious Serum Institute of India
India to supply 1.1 billion doses of COVID-19 vaccines to UNICEF
Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine
South African regulator approves Serum Institute's Covishield days before receiving vaccine
Serum Institute’s Covishield vaccine may be recommended for international use
Covid-19 vaccination drive: After taking the first shot, here's what corona warriors said
Serum Institute Chief Adar Poonawalla takes Covid Vaccine
Inside Serum Institute - India's Covid Vaccine Hub: NDTV Exclusive
Serum Institute Of India sends out Covishield vaccine - Consignment of Covishield Vaccine arrived in Delhi, Chennai, Kolkata, Guwahati, Shillong, Ahmedabad, Hydrabad, Vijayawada, Bhubaneswar, Patna, Bengaluru, Lucknow, Chandigarh
Price of Covishield fixed at Rs 200 per dose, SII to begin shipping Covid-19 vaccine
India's Wait Over, Drug Regulator Says Covid Vaccines Cleared "110% Safe"
'Covishield' ready to roll out in coming weeks, says Serum Institute's Adar Poonawalla
Serum Institute Of India Chairman, Dr. Cyrus Poonawalla's interview with TV 18 on 30 December 2020
Oxford COVID-19 vaccine 95% effective if given 3 months apart, says SII's Adar Poonawalla
Dr. Harsh Vardhan launches Serum Institute Of India's Pneumococcal Conjugate Vaccine - Pneumosil
Serum Institute of India launches India’s first fully indigenously developed pneumococcal vaccine, 'PNEUMOSIL'
Oxford-SII's 'Covishield' likely to be Indias first COVID vaccine
First indigenous vaccine against pneumonia developed by Serum Institute to be launched next week
Serum Institute to soon produce ‘Green Vaccine’
Oxford COVID-19 vaccine: Serum Institute likely to submit final Covishield trial data within 10 days
COVID-19 vaccine: Serum Institute to make 10 crore doses each month from next year
Vaccine rollout will take two months after licensing, says Serum Institute's Poonawalla
Adar Poonawalla, CEO of Serum Institute, named 'Asian of the Year' with 6 others
PM Modi impressed with SII facility, wants vaccine out at earliest: Cyrus Poonawalla
Covid vaccine should be available for public by April 2021: Serum Institute CEO
SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020
COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India
No safety concerns related to the Covishield vaccine trial: Serum chief
Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax
Adar Poonawalla speaks to NDTV about the coronavirus vaccine and it's development
IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
Coronavirus | Vaccine shot ‘painless’, say Covishield trial volunteers
Serum Institute Of India Takes A Multipronged Approach In Quest To Produce World’s First Covid-19 Vaccines
Serum Institute of India to produce up to an additional 100 million covid 19 vaccine doses for india and low and midle income countries in 2021
Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19
Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate
Oxford COVID-19 vaccine: Serum Institute to start final phase of trial in India from Monday
Novavax COVID-19 vaccine: Serum Institute to start trial next month in India
Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID–19
Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses
Will resume Covid-19 vaccine trials after DCGI nod: Serum Institute
Looking forward to the Oxford covid vaccine: Serum Institute CEO
Bangladesh's Beximco signs Covid-19 vaccine deal with India's Serum Institute
Bloomberg School awards highest honor to Poonawalla and Casals
Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India
ICMR helping Serum Institute in conducting clinical trials for two vaccines
Oxford COVID-19 vaccine final trials will be held in these 17 hospitals in India
Serum Institute of India to begin phase 2 trials of Oxford COVID-19 vaccine this week
Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and others
The World’s Best Hope for Enough Covid-19 Vaccine Comes from India
Serum Institute of India Says Covid Vaccine Likely to Be Ready by End of 2020, Final Pricing in 2 Months
Serum institute of india to produce up to 100 million covid-19 vaccine doses for india and low-and middle-income countries as early as 2021
Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute
Serum Institute of India gets approval to start human trials for Oxford vaccine
Serum Institute conducting phase III clinical trial of BCG vaccine: DBT
Julia Chatterley In Conversation with CEO Mr. Adar Poonawalla
Sabina Sanghvi in Conversation with Dr. Cyrus Poonawalla
50% of our Covid vaccines will be for India, people won't have to buy them, govts will pay: Adar Poonawalla
AstraZeneca vaccine's success in early human trials, Will Begin AstraZeneca Vaccine Trial in India After Applying for Licence Next Week, Says Serum Institute
Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’
First Fully Indigenous Pneumonia Vaccine, Developed By Serum Institute, Approved
Serum Institute of India expects COVID vaccine by year-end
Serum Institute of India to supply pneumonia vaccine to low-income nations
New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment
Serum Institute investing USD 100 million on potential COVID-19 vaccine
Adar Poonawalla-backed startup h2e Power acquires Swiss company Hexis AG
Global Vaccine Summit 2020
Oxford University’s COVID-19 vaccine: next steps towards broad and equitable global access
AstraZeneca & Serum Institute of India sign licensing deal for 1 billion doses of Oxford vaccine
Adar Poonawalla's vaccine: No shot in the dark
Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy
To The Point with Adar Poonawalla, CEO & Owner, Serum Institute of India
Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla
Serum Institute to go for human trials for COVID-19 vaccine by year-end, says Adar Poonawala
Mylab partners with SII’s Poonawalla, APG’s Pawar to scale-up production of Covid-19 test kits
Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.
The Indian vaccine king attempting to create a coronavirus cure ‘within six months’
Vaccine for COVID-19 Won’t Be Ready Before 2022, Says World’s Largest Vaccine Producer
New pneumococcal vaccine from Serum Institute of India achieves WHO prequalification
Serum Institute of India & Villoo Poonawalla Foundation to upgrade two English Medium Schools
Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla
Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum
Serum Institute of India's new plant inaugurated by Hon’ble Union Health Minister Dr. Harsh Vardhan
Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.
Serum Founder Wins Inaugural "Vaccine Hero" Award
Adar Poonawalla Received The CNBC Asia's Award For Corporate Social Responsibility Of The Year 2018
Adar Poonawalla is Indian of the Year in CSR Business Category | CNN-News18
PM Nominates Adar Poonawalla As Brand Ambassador For Swachh Bharat
PM Modi lauds Poonawalla’s clean city effort
Prime Minister Narendra Modi visits Serum Institute of India
Adar Poonawalla Clean City Inaugurated By CM Fadnavis
